Healthcare -
Biotechnology - NASDAQ - BM
$ 19.98
0.503 %
$ 1.44 B
Market Cap
-166.5
P/E
KNSA - STOCK-BASED COMPENSATION
Stock-based Compensation KNSA - Kiniksa Pharmaceuticals, Ltd.
27.1 M
LAST VALUE
3.85%
2 YEAR CAGR
36.63%
5 YEAR CAGR
0.00%
10 YEAR CAGR